` Comparison: VRT vs 300015 - Alpha Spread

VRT
vs
A
300015

Over the past 12 months, VRT has underperformed Aier Eye Hospital Group Co Ltd, delivering a return of 0% compared to the Aier Eye Hospital Group Co Ltd's 27% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
VRT
300015
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

VRT Intrinsic Value
Not Available
A
Intrinsic Value
12.5 CNY
Undervaluation 15%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Virtus Health Ltd
ASX:VRT
8.1 AUD
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
10.6 CNY
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
VRT, 300015

VRT
300015
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Virtus Health Ltd
Revenue
A
Aier Eye Hospital Group Co Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
VRT, 300015

VRT
300015
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Virtus Health Ltd
ASX:VRT
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

VRT
71.7%
Aier Eye Hospital Group Co Ltd
46.6%

Operating Margin

VRT
14.1%
Aier Eye Hospital Group Co Ltd
20.3%

Net Margin

VRT
8.7%
Aier Eye Hospital Group Co Ltd
14.5%

FCF Margin

VRT
12.4%
Aier Eye Hospital Group Co Ltd
18.1%

ROE

VRT
8.9%
Aier Eye Hospital Group Co Ltd
15.3%

ROA

VRT
4.7%
Aier Eye Hospital Group Co Ltd
9.4%

ROIC

VRT
6.2%
Aier Eye Hospital Group Co Ltd
13.9%

ROCE

VRT
8.6%
Aier Eye Hospital Group Co Ltd
16.6%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
VRT, 300015

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
VRT, 300015

Loading
VRT
300015
Difference
www.alphaspread.com

Performance By Year
VRT, 300015

Loading
VRT
300015
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare VRT to other stocks
HCA
HCA Healthcare Inc
Cheaper
vs VRT
4013
Dr Sulaiman Al-Habib Med...
Cheaper
vs VRT
NTC
Netcare Ltd
N
Cheaper
vs VRT
THC
Tenet Healthcare Corp
Cheaper
vs VRT
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett